TY - JOUR
T1 - High-resolution Structural and Thermodynamic Analysis of Extreme Stabilization of Human Procarboxypeptidase by Computational Protein Design
AU - Dantas, Gautam
AU - Corrent, Colin
AU - Reichow, Steve L.
AU - Havranek, James J.
AU - Eletr, Ziad M.
AU - Isern, Nancy G.
AU - Kuhlman, Brian
AU - Varani, Gabriele
AU - Merritt, Ethan A.
AU - Baker, David
N1 - Funding Information:
We thank the facilities at NMRFAM (Madison, WI, supported by NIH) and PNNL (Richland, WA, supported by DOE) for access to NMR instrumentation. This work was supported, in part, by NIH grants to G.V., B.K. and D.B.
PY - 2007/3/2
Y1 - 2007/3/2
N2 - Recent efforts to design de novo or redesign the sequence and structure of proteins using computational techniques have met with significant success. Most, if not all, of these computational methodologies attempt to model atomic-level interactions, and hence high-resolution structural characterization of the designed proteins is critical for evaluating the atomic-level accuracy of the underlying design force-fields. We previously used our computational protein design protocol RosettaDesign to completely redesign the sequence of the activation domain of human procarboxypeptidase A2. With 68% of the wild-type sequence changed, the designed protein, AYEdesign, is over 10 kcal/mol more stable than the wild-type protein. Here, we describe the high-resolution crystal structure and solution NMR structure of AYEdesign, which show that the experimentally determined backbone and side-chains conformations are effectively superimposable with the computational model at atomic resolution. To isolate the origins of the remarkable stabilization, we have designed and characterized a new series of procarboxypeptidase mutants that gain significant thermodynamic stability with a minimal number of mutations; one mutant gains more than 5 kcal/mol of stability over the wild-type protein with only four amino acid changes. We explore the relationship between force-field smoothing and conformational sampling by comparing the experimentally determined free energies of the overall design and these focused subsets of mutations to those predicted using modified force-fields, and both fixed and flexible backbone sampling protocols.
AB - Recent efforts to design de novo or redesign the sequence and structure of proteins using computational techniques have met with significant success. Most, if not all, of these computational methodologies attempt to model atomic-level interactions, and hence high-resolution structural characterization of the designed proteins is critical for evaluating the atomic-level accuracy of the underlying design force-fields. We previously used our computational protein design protocol RosettaDesign to completely redesign the sequence of the activation domain of human procarboxypeptidase A2. With 68% of the wild-type sequence changed, the designed protein, AYEdesign, is over 10 kcal/mol more stable than the wild-type protein. Here, we describe the high-resolution crystal structure and solution NMR structure of AYEdesign, which show that the experimentally determined backbone and side-chains conformations are effectively superimposable with the computational model at atomic resolution. To isolate the origins of the remarkable stabilization, we have designed and characterized a new series of procarboxypeptidase mutants that gain significant thermodynamic stability with a minimal number of mutations; one mutant gains more than 5 kcal/mol of stability over the wild-type protein with only four amino acid changes. We explore the relationship between force-field smoothing and conformational sampling by comparing the experimentally determined free energies of the overall design and these focused subsets of mutations to those predicted using modified force-fields, and both fixed and flexible backbone sampling protocols.
KW - Computational protein design
KW - High-resolution protein structure
KW - Procarboxypeptidase A2
KW - Rosetta
KW - Thermodynamic stabilization
UR - http://www.scopus.com/inward/record.url?scp=33846603216&partnerID=8YFLogxK
U2 - 10.1016/j.jmb.2006.11.080
DO - 10.1016/j.jmb.2006.11.080
M3 - Article
C2 - 17196978
AN - SCOPUS:33846603216
SN - 0022-2836
VL - 366
SP - 1209
EP - 1221
JO - Journal of Molecular Biology
JF - Journal of Molecular Biology
IS - 4
ER -